| Literature DB >> 32647469 |
Hazim Mohamed Rizk1, Mohamed Sherif Mohamed Salah Al-Deen1, Asmaa Aly Emam1.
Abstract
OBJECTIVES: The research aims to assess the regenerative potential of Platelet Rich Plasma (PRP) versus Platelet Rich Fibrin (PRF) scaffolds in immature permanent maxillary central incisors with necrotic pulps, clinically and radiographically. TRIALEntities:
Keywords: Immature necrotic permanent maxillary central incisors; Platelet rich plasma; Platelet‑rich fibrin; Revascularization/revitalization
Year: 2019 PMID: 32647469 PMCID: PMC7336024 DOI: 10.1016/j.sdentj.2019.09.002
Source DB: PubMed Journal: Saudi Dent J ISSN: 1013-9052
Fig. 1An example from both groups; PRP tooth #11 vs. PRF tooth #21: Necrotic immature fractured teeth with an open apex in an 9-years-old boy and 8-years old girl respectively. (A) Pre-operative periapical radiograph; (B) After the placement of mineral trioxide aggregate; (C) At 6-month follow-up, with development of the root; (D) At 12-month follow-up, with continued development of the root apex.
Fig. 2CONSORT 2010 flow diagram.
Sample description according to the basic characteristics of the patients.
| Variable | PRP | PRF | P value |
|---|---|---|---|
| Mean ± SD | 9.08 ± 1.038 | 9.08 ± 1.165 | 0.989 |
| Male | 7 (53.8%) | 6(50%) | 0.582 |
| Female | 6 (46.2%) | 6 (50%) | |
| Enamel-Dentin-Pulp fracture | 7 (53.8%) | 11(91.7%) | 0.013 |
| Enamel-Dentin | 6(46.2%) | 1 (8.3%) | 0.013 |
| No loss of tooth structure | 0 (0%) | 0 (0%) | |
*Significant at P-value < 0.1.
SD = Standard Deviation
Highly significant at P-value < 0.05.
The increase in root length in millimeters and percentage of the PRP and PRF groups during the four evaluation periods.
| PRP group (mean ± SD) | PRF group (mean ± SD) | p-value | |
|---|---|---|---|
| 3 months (mm, %) | 0.225 ± 0.19 (1.52%±1.43%) | 0.155 ± 0.099 (1.02%±0.673%) | 0.406 |
| 6 months (mm, %) | 0.557 ± 0.23 (3.7%±1.43%) | 0.391 ± 0.187 (2.57%±1.23%) | 0.127 |
| 9 months (mm, %) | 0.996 ± 0.35 (6.6%±2.4%) | 0.793 ± 0.378 (5.2%±2.48%) | 0.174 |
| 12 months (mm, %) | 1.48 ± 0.37 (9.88%±2.85%) | 1.24 ± 0.54 (8.19%±3.64%) | 0.355 |
*Significant at P-value < 0.1.
**Highly significant at P-value < 0.05.
SD = Standard Deviation
The increase in root width in millimeters and the percentage of the PRP and PRF groups during the four evaluation periods.
| PRP group (mean ± SD) | PRF group (mean ± SD) | p-value | |
|---|---|---|---|
| 3 months (mm, %) | 0.153 ± 0.128 (6.03% ± 5.03%) | 0.19494 ± 0.172 (7.9% ± 6.2%) | 0.47 |
| 6 months (mm, %) | 0.445 ± 0.41 (18.05%±17.45%) | 0.474 ± 0.299 (19.97% ± 12.08%) | 0.503 |
| 9 months (mm, %) | 0.739 ± 0.56 (29.65%±23.9%) | 0.73517 ± 0.34 (30.77% ± 13.26%) | 0.503 |
| 12 months (mm, %) | 0.97 ± 0.75 (39.27% ± 32.04%) | 1.003 ± 0.392 (42.37% ± 16.49%) | 0.574 |
*Significant at P-value < 0.1.
**Highly significant at P-value < 0.05.
SD = Standard Deviation
The increase in bone density in grey value and percentage of the PRP and PRF groups during the four evaluation periods.
| PRP group (mean ± SD) | PRF group (mean ± SD) | p-value | |
|---|---|---|---|
| 3 months (grey value, %) | 24.87 ± 16.63 (27.605% ± 19.89%) | 15.64 ± 11.1 (45.14% ± 74.78%) | 0.345 |
| 6 months (grey value, %) | 34.42 ± 21.03 (42.3% ± 25.46%) | 28.2 ± 16.7 (80.6% ± 145.1%) | 0.345 |
| 9 months (grey value, %) | 52.47 ± 25.39 (57.74% ± 31.36%) | 40.79 ± 19.12 (109.29% ± 171.22%) | 0.414 |
| 12 months (grey value, %) | 65.08 ± 30.043 (71.84% ± 30.043%) | 53.44 ± 22.165 (137.4% ± 203.02%) | 0.345 |
*Significant at P-value < 0.1.
**Highly significant at P-value < 0.05.
SD = Standard Deviation
The decrease in apical diameter in millimeters and percentage of the PRP and PRF groups during the four evaluation periods.
| PRP group (mean ± SD) | PRF group (mean ± SD) | p-value | |
|---|---|---|---|
| 3 months (mm, %) | 0.25 ± 0.167 (9.91%±6.03%) | 0.34 ± 0.2 (15.7%±8.84%) | 0.246 |
| 6 months (mm, %) | 0.656 ± 0.43 (27.29%±14.1%) | 0.87 ± 0.48 (38.23%±15.03%) | 0.123 |
| 9 months (mm, %) | 2.17 ± 3.86 (51.98%±19.64%) | 1.33 ± 0.57 (58.89%±10.59%) | 0.611 |
| 12 months (mm, %) | 2.49 ± 3.93 (64.83%±18.5%) | 1.73 ± 0.665 (76.75%±8.5%) | 0.437 |
*Significant at P-value < 0.1.
**Highly significant at P-value < 0.05.
SD = Standard Deviation